A specialized organizational structure consolidates the process of analyzing biological specimens for the presence of prohibited substances. This consolidation streamlines operations by bringing all testing activities under a single point of management and control. For example, a large corporation might establish a single laboratory to handle all employee drug screenings, instead of contracting with multiple external providers at different locations.
This approach offers several advantages, including enhanced consistency in testing protocols, improved quality control, and the potential for economies of scale. Centralizing the function allows for the standardization of procedures, resulting in more reliable and defensible results. Furthermore, historical precedent shows that consolidated efforts often reduce operational costs and improve overall efficiency compared to decentralized models due to reduced redundancy and bulk purchasing power.
